Egypt's state-owned Holding Company for Biological Products and Vaccines (VACSERA) has signed an MoU with UAE-based Al Qalaa Investments and China's Red Flag, the Ministry of Health and Population announced on Wednesday. The agreement aims to boost the company's production capacity for human and veterinary vaccines, as well as plasma used in serum manufacturing, to support national capabilities in this vital sector. This partnership is part of the state's strategy to attract foreign investment, localise the vaccine industry, and strengthen national capabilities in scientific research, development, and bioproduction. The partnership is in line with Egypt Vision 2030, aiming to attain self-sufficiency and sustainable development in the healthcare sector, and would bolster Egypt's role as a regional centre for the manufacturing of biological products. Attribution: Amwal Al Ghad English Subediting: M. S. Salama